Advertisement Teva UK introduces generic inhaler - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Teva UK introduces generic inhaler

Teva UK has launched a generic inhaler to prevent breathing problems caused by asthma.

The inhaler, Salmeterol pMDI does not contain Chlorofluorocarbon (CFC) which can cause environmental damage.

The product comes in 25mcg per actuation pressurised inhalation, suspension in a green inhaler.

Teva UK, a subsidiary of Teva Pharmaceutical is a provider of liquid dose, injectable and respiratory medicines to healthcare professionals.